Author Guidelines

Title Page

• Title: No abbreviations should be used.
o Maximum length: 150 characters (including spaces) o Short title limit: 50 characters (without spaces)

• Authors: Include full names, department, and institutional affiliation.

• Corresponding Author: Provide the full name, complete address, email ID, phone number, and fax number.

• Disclosures: Authors must disclose any potential conflicts of interest (financial, professional, or personal). If no

  conflicts exist, a statement must be included.

• Grant Support: List any available grants and other forms of funding.

• Abbreviations: Provide a list of abbreviations used in the document in alphabetical order.

  ✓ Abstract

  The abstract should be no more than 250 words and include the reasoning, aims, findings, and conclusions of the manuscript. It should be written for a broad audience and must not contain nonstandard abbreviations, references, or main data.

  IJPPR reserves the right to reword abstracts for publication with the author's final approval.

  ✓ Body of Paper

  Body of Paper

  Manuscripts (including references and tables) should be 1.15 spacing. If necessary, single-spaced figure legends can be used to maintain the picture and legend on the same page. All pages should be numbered. The average length of a manuscript is 6,500 words, which includes all legends and references; however, the IJPPR does not have a fixed word restriction.

  Introduction

  The paper should include a thorough foundation for the current investigation, as well as a summary of the work after the introduction.

  Materials and Methods

  All experimental techniques, including the source of chemicals and medications, should be described in full in the report. Generic names can be used to identify medications and substances (wherever trademarks are mentioned, manufacturer name and city name should be provided). Describe the ethical rules that were followed (for human or animal experiments); reference institutional human research review committee or animal welfare committee permission; and describe in full any hazardous methods or substances that were used, including any safeguards taken. Please also describe the statistical approaches employed.

• Results

  The findings should be presented clearly and straightforwardly. Tables and figures should be prepared to make the experimental results as easy to understand as possible. The issue of big figures should be taken into consideration (usually, no more than six, including tables). The same information should not be shown in more than one figure or both a figure and a table. In most cases, interpretation of the results should be saved for the discussion portion of a Research Article, but in rare cases, combining findings and discussion in a single section may be appropriate. Deliberation The goal of the talk is to clearly and concisely understand the results and tie them to current knowledge on the topic. The discussion should not repeat information found elsewhere in the manuscript. Extensive literature reviews should be avoided. International Journal of Pharma Professional’s Research accepts manuscripts written in American English.

  Copies of any permission(s)

  Authors/contributors are responsible for obtaining rights before copying any copyrighted content. A copy of the authorization acquired must accompany the manuscript. All published articles and any papers under preparation or submitted elsewhere that are linked to the work must also be included. Send the materials to one of the two addresses listed above.

  ✓ Types of Manuscripts Accepted

  • Original Research Articles

  • Review Articles

Case Reports

Types of Manuscripts

Original articles:

RCTs, intervention studies, screening and diagnostic test studies, outcome studies, cost-effectiveness analyses, case- control studies, and surveys with a high response rate are among them. Original articles of up to 3000 words should be organized into parts with headings. Abstract, Keywords, Introduction, Material and Methods, Results, Discussion, References, Tables, and Figure Legends.

Introduction: State the purpose and summarize the rationale for the study or observation.

Materials and Methods: It should include and describe the following aspects:

Ethics: Indicate if the methods followed were under the competent committee on human experimentation's ethical norms (institutional or regional) and the Helsinki Declaration of 1975, as updated in 2000 (available at http://www.wma.net/e/policy/17-c e.html). The approval of (regional/ national/ institutional or independent Ethics Committee or Review Board, obtaining informed consent from adult research participants, and obtaining assent for children aged over 7 years participating in the trial are all expected to be mentioned in prospective studies involving human participants. The age at which assent is necessary may vary depending on regional and/or national norms. Avoid disclosing participants' names, initials, or hospital numbers, especially in illustrated material, to ensure subject anonymity. Indicate if the institution's or a national research council’s recommendation for or any national law on the care and use of laboratory animals were followed when reporting animal studies. The authors must provide evidence on demand for approval by a local Ethics Committee (for both human and animal experiments). The use of anesthetics and analgesics in animal experiments should be as compassionate as feasible, and the specifics of the anesthetics and analgesics employed should be properly reported. The recommendations set by the CPCSEA and the World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Using Humans for research involving experimental animals and human beings, respectively, must be followed when conducting experiments. Any work that violates the journal's ethical guidelines will be rejected. Under the ‘Materials and Methods' section, all research publications must include a declaration on ethics committee approval and ethical procedures.